NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study

by admin | Jun 28, 2022 | Blog, Clinical trials, Expanded Access Programs, News

... Read More | Share it now!

FDA Releases Action Plan for Rare Neurodegenerative Diseases, Including ALS

by admin | Jun 23, 2022 | Blog

... Read More | Share it now!

SBT-272, in Phase 1 Trial, Continues to Protect Motor Neurons in Mice

by admin | Jun 22, 2022 | Blog, Clinical trials

... Read More | Share it now!

Danger Of Gum Disease

by admin | Jun 20, 2022 | Blog, The Brain

... Read More | Share it now!

Gene discovery indicates motor neurone diseases caused by abnormal lipid processing in cells

by admin | Jun 20, 2022 | Blog

... Read More | Share it now!

New Study Investigating Long-term Safety, Effectiveness of Reldesemtiv

by admin | Jun 20, 2022 | Blog, Clinical trials

... Read More | Share it now!